CYP2C9

The 3X4 Genetics Test + Blueprint Report provides 36 key insights and practical, personalized recommendations for patients to start taking control of their health.

The PgX (Pharmacogenomic) Test examines a patient's inherited genes to detect variations that may impact how a drug is broken down, absorbed, and used within the body.

The DetoxiGenomic® Profile uses genomic testing to identify a patient's risk for chemical sensitivities, oxidative stress, and the ability to handle various medications.

MedCheck gives insights into a patient's responsiveness to different medications and the likelihood of side effects and treatment failure. It provides insight into how a patient metabolizes, transports, and binds specific drugs, allowing physicians to prescribe medications that are most likely to prove effective with minimal side effects.

This test assesses a patient's genetic predisposition to the negative effects of pain or a poor reaction to pain management medication.